MediPharm Labs (TSE:LABS) has released an update.
MediPharm Labs, a leading pharmaceutical company specializing in cannabinoid products, is set to release its third quarter 2024 financial results on November 14 before markets open. The company has expanded its reach through strategic acquisitions and continues to operate with a focus on quality and compliance in international markets.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
